Carbapenemase-producing Enterobacteriaceae (CPE) infections are
increasing throughout the world and carry high mortality. There are some reports
of CPE peritonitis in peritoneal dialysis (PD) patients. We report a case of
PD-related peritonitis from carbapenemase-producing Klebsiella
pneumoniae with OXA-48 type gene. The emphasis is on early clinical
suspicion, appropriate antibiotics, and timely catheter removal.
Van DuinD., DoiY.The global epidemiology of carbapenemase-producing
Enterobacteriaceae.Virulence2017; 8(4):
460–9.
2.
ChewK.L., LinR.T.P., TeoJ.W.P.Klebsiella pneumoniae in Singapore:
hypervirulent infections and the carbapenemase threat.Front Cell Infect Microbiol2017; 7: 515.
3.
TolemanM.A.The future of peritoneal dialysis in a moving landscape of
bacterial resistance.Perit Dial Int2017; 37(2):
134–40.
4.
CheungC.Y., ChanS.Y., YeungC.S., ChakW.L., WuT.C., ChauK.F.Carbapenem-resistant Enterobacteriaceae as a
cause of peritonitis in a peritoneal dialysis patient.Nephrology (Carlton)2016; 21(10):
906–7.
5.
VillegasM.V., PallaresC.J.,
Escandon-VargasK.,
Hernandez-GomezC., CorreaA., AlvarezC.Characterization and clinical impact of bloodstream infection
caused by carbapenemase-producing Enterobacteriaceae in
seven Latin American countries.PLOS One2016; 11(4):
e0154092.
6.
HusseinK., Raz-PasteurA., FinkelsteinR., NeubergerA.,
Shachor-MeyouhasY., OrenI.Impact of carbapenem resistance on the outcome of
patients’ hospital-acquired bacteraemia caused by Klebsiella
pneumoniae.J Hosp Infect2013; 83(4):
307–13.
